1.646.889.1200|info@lifescipublicrelations.com

Oxurion introduces new clinical portfolio at OIS

/, video/Oxurion introduces new clinical portfolio at OIS

Oxurion introduces new clinical portfolio at OIS

CHICAGO: At the Ophthalmology Innovation Summit at AAO, Patrik De Haes, MD, CEO of Oxurion, introduces the company’s new clinical portfolio with three separate molecules in clinical trials for the treatment of diabetic macular edema.

By | 2018-11-08T15:45:46-04:00 November 7th, 2018|News, video|Comments Off on Oxurion introduces new clinical portfolio at OIS

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.